Evidence Detail for LY96

Basic Information
Top
| Gene Symbol: | LY96 ( ESOP-1,MD-2,MD2,ly-96 ) |
|---|
| Gene Full Name: | lymphocyte antigen 96 |
|---|
| Band: | 8q21.11 |
|---|
| Quick Links | Entrez ID:23643; OMIM: 605243; Uniprot ID:LY96_HUMAN; ENSEMBL ID: ENSG00000154589 |
|---|
>LY96|23643|nucleotide
ATGTTACCATTTCTGTTTTTTTCCACCCTGTTTTCTTCCATATTTACTGAAGCTCAGAAGCAGTATTGGGTCTGCAACTCATCCGATGCAAGTATTTCATACACC
TACTGTGGGAGAGATTTAAAGCAATTATATTTCAATCTCTATATAACTGTCAACACCATGAATCTTCCAAAGCGCAAAGAAGTTATTTGCCGAGGATCTGATGAC
GATTACTCTTTTTGCAGAGCTCTGAAGGGAGAGACTGTGAATACAACAATATCATTCTCCTTCAAGGGAATAAAATTTTCTAAGGGAAAATACAAATGTGTTGTT
GAAGCTATTTCTGGGAGCCCAGAAGAAATGCTCTTTTGCTTGGAGTTTGTCATCCTACACCAACCTAATTCAAATTAG
« Hide>LY96|23643|protein
MLPFLFFSTLFSSIFTEAQKQYWVCNSSDASISYTYCGRDLKQLYFNLYITVNTMNLPKRKEVICRGSDDDYSFCRALKGETVNTTISFSFKGIKFSKGKYKCVV
EAISGSPEEMLFCLEFVILHQPNSN
« Hide 
Evidence Statistic
Top
Click the link of the category-specific score to view different category of evidences. The categories without any evidences are hidden by default. 
Syndromic Autism Gene
Top

Low Scale Association Studies (by Ethnic Group)
Top
Family Based Association Studies: 0
| Reference |
Population |
#SNPs/ #VNTRs |
#Families |
Affecteds |
Result |
#Subjects (% Women) |
ADI-R |
ADOS |
Diagnosis |
Age (range) |
IQ (range) |
| No Evidence. |
Case Control Based Association Studies: 0
| Reference |
Population |
#SNPs/ #VNTRs |
ASD Cases |
Normal Controls |
Result |
#Subjects (% Women) |
ADI-R |
ADOS |
Diagnosis |
Age (range) |
IQ |
#Subjects (% Women) |
Age (range) |
| No Evidence. |

Genome-Wide Association Studies(By Ethnic Group)
Top
Family Based Association Studies: 0
| Reference |
Stage |
#SNPs/ #VNTRs |
#Families |
Affecteds |
Result |
#Subjects (% Women) |
ADI-R |
ADOS |
Diagnosis |
Age (range) |
IQ (range) |
| No Evidence. |
Case Control Based Association Studies: 0
| Reference |
Stage |
#SNPs/ #VNTRs |
ASD Cases |
Normal Controls |
Result |
#Subjects (% Women) |
ADI-R |
ADOS |
Diagnosis |
Age (range) |
IQ |
#Subjects (% Women) |
Age (range) |
| No Evidence. |

Other Low Scale Gene Studies
Top
| Reference |
Orangnism |
Tissue |
ADI-R |
ADOS |
Diagnosis |
Evidence Level |
Result |
| No Evidence. |

Large Scale Expression Studies
Top
Microarray Studies: 3
| Reference |
Population |
Tissue |
#Subjects (% Women) |
ADI-R |
ADOS |
Endo- pheno |
Diagnosis |
Normal Controls (% Women) |
Fold Change |
Up/ Down |
P/Q value |
| Garbett, 2008_1 |
Unknown |
superior temporal gyrus (STG) |
6 (33.33%) | - | - | - | autism |
6 (33.33%) |
1.12568 |
Up |
0.0168672 | |
- Platform: Affymetrix Human Genome 133 plus 2 microarrays
- ProbeSet: 206584_at
- RefSeq_ID/ EST: -
- GEO_ID: -
- Statistic Method: pairwise/groupwise two-tailed t-test between the RMA intensities of AUT and CONT samples
|
| Voineagu, 2011_1 |
Unknown |
16 frontal cortex(BA9) and 13 temporal cortex(BA41 |
16 (25.00%) |  |  | - | autism |
16 (6.25%) |
1.42208 |
Up |
0.183255 | |
- Platform: Illumina Ref8 v3 microarrays
- ProbeSet: ILMN_1724533
- RefSeq_ID/ EST: -
- GEO_ID: GSE28521
- Statistic Method: SAM package and unless otherwise specified the significance threshold was FDR,0.05 and fold changes.1.3.
|
| Voineagu, 2011_2 |
Unknown |
frontal, BA44/45 |
10 (0.00%) |  |  | - | autism |
6 (0.00%) |
2.09929 |
Up |
0.0262834 | |
- Platform: Illumina Ref8 v4 microarrays
- ProbeSet: ILMN_1724533
- RefSeq_ID/ EST: -
- GEO_ID: GSE28521
- Statistic Method: SAM package and unless otherwise specified the significance threshold was FDR,0.05 and fold changes.1.3.
|
Proteomics Studies:0
| Reference |
Population |
Tissue |
Platform |
#Subjects (% Women) |
ADI-R |
ADOS |
Diagnosis |
Normal Controls(% Women) |
| No Evidence. |

CNV Studies
Top
| CNV Name |
Chr |
Band |
Gain/Loss |
Number of CNVs |
Evidence Type |
Reference |
| Case |
Control |
| No matched CNVs ! |

Linkage Studies
Top
| Linkage Name |
Band |
Chr |
Marker |
LOD |
NPL |
P_Value |
Reference |
| No Matched Linkage Regions ! |
Contact Us if you are an author of a study regarding this gene and do not find your study in this table or find errors in the representation of your study details.